Skip to content

HCPS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HCPS

BE 0606.991.851
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€16,669
2024 · €12,069+€4,599
Equity
€49,223
2024 · €102,554-€53,331
Cash
€3,421
2024 · €62,275-€58,854
Balance sheet total
€80,577
2024 · €128,953-€48,376

Largest movements

2024 to 2025
Assets
  • Cash -€58,854

    down €58,854 (-94.5%), from €62,275 to €3,421

    mainly Contributions, distributions and other (-€70,000) and Receivables within one year (-€29,525)

  • Receivables within one year +€29,525

    up €29,525 (+66.1%), from €44,636 to €74,162

    of which Trade receivables: +€33,025

  • Deferred charges and accrued income -€13,148

    down €13,148 (-94.7%), from €13,889 to €741

  • Tangible fixed assets -€4,295

    down €4,295 (-96.2%), from €4,463 to €169

    of which Plant, machinery and equipment: -€3,562

  • Intangible fixed assets -€1,605

    down €1,605 (-100%), from €1,605 to €0

Equity and liabilities
  • Contributions -€70,000

    down €70,000 (-89.1%), from €78,600 to €8,600

  • Reserves +€16,669

    up €16,669 (+69.6%), from €23,954 to €40,623

  • Other debts +€14,098

    up €14,098 (+620%), from €2,275 to €16,373

  • Tax, wage and social debts -€12,433

    down €12,433 (-52.3%), from €23,776 to €11,343

  • Trade debts +€3,290

    up €3,290 (+944%), from €348 to €3,638

Income statement
  • Depreciation -€25,890

    down €25,890 (-81.4%), from €31,789 to €5,900

  • Gross operating margin -€16,365

    down €16,365 (-31.7%), from €51,564 to €35,199

  • Taxes +€3,735

    up €3,735 (+60.6%), from €6,160 to €9,895

  • Financial charges +€958

    up €958 (+256%), from €374 to €1,332

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €12,069
Gross operating margin -€16,365
Depreciation +€25,890
Other operating charges -€234
Financial income +€1
Financial charges -€958
Taxes -€3,735
Result 2025 €16,669
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€11,146
Investment €0
Financing -€70,000
Cash 2024 €62,275
Net result for the year +€16,669
Depreciation +€5,900
Receivables within one year -€29,525
Deferred charges and accrued income +€13,148
Trade debts +€3,290
Tax, wage and social debts -€12,433
Other debts +€14,098
Contributions, distributions and other -€70,000
Cash 2025 €3,421
brings cash intakes cash out
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €128,953 €80,577 -€48,376 -37.5%
Fixed assets 21/28 €6,653 €754 -€5,900 -88.7%
Intangible fixed assets 21 €1,605 €0 -€1,605 -100%
Tangible fixed assets 22/27 €4,463 €169 -€4,295 -96.2%
Plant, machinery and equipment 23 €3,562 €0 -€3,562 -100%
Furniture and vehicles 24 €902 €169 -€733 -81.3%
Financial fixed assets 28 €585 €585 = 0.0%
Current assets 29/58 €122,300 €79,824 -€42,476 -34.7%
Stocks and contracts in progress 3 €1,500 €1,500 = 0.0%
Stocks 30/36 €1,500 €1,500 = 0.0%
Amounts receivable within one year 40/41 €44,636 €74,162 +€29,525 +66.1%
Trade receivables 40 €40,796 €73,822 +€33,025 +81.0%
Other amounts receivable 41 €3,840 €340 -€3,500 -91.1%
Cash at bank and in hand 54/58 €62,275 €3,421 -€58,854 -94.5%
Deferred charges and accrued income 490/1 €13,889 €741 -€13,148 -94.7%
Total equity and liabilities 10/49 €128,953 €80,577 -€48,376 -37.5%
Equity 10/15 €102,554 €49,223 -€53,331 -52.0%
Contributions 10/11 €78,600 €8,600 -€70,000 -89.1%
Reserves 13 €23,954 €40,623 +€16,669 +69.6%
Distributable reserves 133 €23,954 €40,623 +€16,669 +69.6%
Amounts payable 17/49 €26,399 €31,354 +€4,955 +18.8%
Amounts payable within one year 42/48 €26,399 €31,354 +€4,955 +18.8%
Trade debts 44 €348 €3,638 +€3,290 +944%
Suppliers 440/4 €348 €3,638 +€3,290 +944%
Taxes, remuneration and social security 45 €23,776 €11,343 -€12,433 -52.3%
Taxes 450/3 €23,776 €11,343 -€12,433 -52.3%
Other amounts payable 47/48 €2,275 €16,373 +€14,098 +620%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €31,789 €5,900 -€25,890 -81.4%
Other operating charges 640/8 €1,171 €1,404 +€234 +20.0%
Gross operating margin 9900 €51,564 €35,199 -€16,365 -31.7%
Operating profit (loss) 9901 €18,604 €27,895 +€9,291 +49.9%
Financial income 75/76B - €1 +€1
Recurring financial income 75 - €1 +€1
Financial charges 65/66B €374 €1,332 +€958 +256%
Recurring financial charges 65 €374 €1,332 +€958 +256%
Profit (loss) for the period before taxes 9903 €18,229 €26,564 +€8,334 +45.7%
Income taxes 67/77 €6,160 €9,895 +€3,735 +60.6%
Profit (loss) for the period 9904 €12,069 €16,669 +€4,599 +38.1%
Profit (loss) for the period to be appropriated 9905 €12,069 €16,669 +€4,599 +38.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.